Who we are
We are the people who open the box
Mycelia Health buys psilocybin products off the shelf, has them tested in accredited labs, and publishes what comes back. We do not sell anything, and no brand can pay us for a result.
Why this exists
Psilocybin is sold openly across Canada and, in a growing number of places, the United States. Almost none of it is tested the way a supplement or a medicine would be. A capsule that says 125mg on the label might hold 40mg, or 300mg, or a blend of something else entirely. Nobody is checking, and the person swallowing it has no way to find out.
We started because that gap is unfair to the person taking the product and unfair to the brands doing it properly. Both problems have the same fix, which is real data, published where anyone can read it.
What we actually do
- We buy products anonymously, at retail, like any other customer.
- We send samples to accredited third party laboratories.
- We publish every result in full, including the ones that fail.
- We write guidance for people using these products, whether or not a brand comes out of it looking good.
We are a research organization, not a retailer and not a marketing agency. We have no products, no affiliate links, and no financial stake in any brand on this site.
The person who runs the testing
Megan Platt handles our hands on work. She is a student at the University of Michigan who came to this because she believes in what psilocybin can do for people, and she wanted to be the one making sure that what reaches them has actually been checked. She buys the products, logs what arrives, sends the samples out, and turns what the lab returns into something a person can read without a chemistry degree.
Megan Platt
Tester and researcher, University of Michigan.
Megan runs and documents the hands on product testing, from purchase through to the published result. If a result on this site looks careful, that is her.
The scientists who keep us honest
Our methods are guided by two tenured mycology professors at major American research universities. Between them they hold decades of peer reviewed work in fungal evolution, genetics, phylogenetics, and the ecology of fungal communities. Both built those careers on the fundamental biology of fungi long before the current wave of psychedelic interest, rather than inside the psilocybin industry.
They have asked us not to publish their names, and we respect that completely. Psilocybin research still carries real professional and institutional risk, and independence means protecting the people who make our work credible rather than putting them in a difficult position for helping.
Here is what we can tell you. Both hold full professorships. Neither holds a financial stake in any brand we review. Neither is paid based on what our tests conclude. Their job is to keep our methods defensible. Ours is to keep their names out of it.
If a mix of named and unnamed people feels unusual for a research group, it is. We think it is the honest version, and we would rather explain it than pretend otherwise.
Where we work
Canada and the United States. Product availability, legal status, and shipping rules differ enormously between the two, and sometimes between provinces and states, so we note where each product was bought.